AJP - Heart Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 266: H583-H589, 1994;
0363-6135/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moroi, M.
Right arrow Articles by Yamaguchi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moroi, M.
Right arrow Articles by Yamaguchi, T.

AJP - Heart and Circulatory Physiology, Vol 266, Issue 2 583-H589, Copyright © 1994 by American Physiological Society


ARTICLES

Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries

M. Moroi, N. Akatsuka, M. Fukazawa, K. Hara, M. Ishikawa, J. Aikawa, A. Namiki and T. Yamaguchi
Third Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.

The effects of angiotensin-converting enzyme (ACE) inhibitors on vascular reactivity were investigated using isolated canine femoral arteries with and without endothelium. N-N-(S)-1-carboxy-3-phenylpropyl-L-alanyl-N-(indan-2-yl)glycine (M-1; an active metabolite of delapril, a nonsulfhydryl ACE inhibitor) and captopril (a sulfhydryl ACE inhibitor, 10(-8) to 10(-5) M) relaxed in a dose-dependent manner canine femoral arterial rings precontracted with prostaglandin F2 alpha in the presence of endothelium only. The endothelium-dependent relaxations by M-1 and captopril were completely blocked by methylene blue, an inhibitor of soluble guanylate cyclase; NG-monomethyl-L-arginine (L-NMMA), an inhibitor of nitric oxide synthesis; and oxyhemoglobin, an inactivator of nitric oxide; they were partially blocked by aspirin, an inhibitor of cyclooxygenase and were enhanced by superoxide dismutase, a radical scavenger. The inhibitory effect of L-NMMA on the relaxations by M-1 and captopril were reversed by a high dose of L-arginine. Moreover, a bradykinin antagonist partially inhibited these relaxations. These results suggest that endothelium-dependent relaxations by M-1 and captopril in canine femoral arteries are mediated through the release of both prostanoids and endothelium-derived nitric oxide via endogenous bradykinin.


This article has been cited by other articles:


Home page
HypertensionHome page
X. Zhang, G. A. Scicli, X. Xu, A. Nasjletti, and T. H. Hintze
Role of Endothelial Kinins in Control of Coronary Nitric Oxide Production
Hypertension, November 1, 1997; 30(5): 1105 - 1111.
[Abstract] [Full Text]


Home page
HypertensionHome page
X. Deng, W. J. Welch, and C. S. Wilcox
Role of Nitric Oxide in Short-term and Prolonged Effects of Angiotensin II on Renal Hemodynamics
Hypertension, May 1, 1996; 27(5): 1173 - 1179.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online